Effect of antileukaemic chemotherapy on helper and suppressor activity of T cells on immunoglobulin production by B cells.
D000368:Aged; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D003561:Cytarabine / Q000494:pharmacology; D003630:Daunorubicin / Q000494:pharmacology; D004359:Drug Therapy, Combination; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis*; D007165:Immunosuppression Therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000276:immunology*; D008211:Lymphocyte Cooperation / Q000187:drug effects; D008875:Middle Aged; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D013866:Thioguanine / Q000494:pharmacology
D000970:Antineoplastic Agents; D007074:Immunoglobulin G; D003561:Cytarabine; D013866:Thioguanine; D003630:Daunorubicin